What You Should Know: - Type 2 diabetes reversal leader Virta Health revealed promising one-year outcomes from its partnership with AutoZone, Inc., a retailer and distributor of automotive replacement parts and accessories in the Americas. - Virta provides virtual, continuous health coaching, medical supervision and personalized nutrition to help patients reverse their metabolic disease, lose weight, + get off medications. At one year, AutoZoners experience long-term blood sugar control
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 billion. Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. Visa had established a stranglehold on financial transactions. The Justice Department moved to stop the acquisition on grounds that Plaid posed “a threat to this monopoly: it has been developing an innovative
Read More
HLTH22: Rimidi Launches New Respiratory Module to Deliver Better Treatment
What You Should Know: - Rimidi launches its new Respiratory Module through integration with Teva Pharmaceuticals’ digital inhalers that be integrated into healthcare provider workflows, enhancing respiratory care and population health management. - This new module allows providers to comprehend the full picture of the patient's disease status both in the clinic and at home – giving clinical teams the tools they need to make personalized, predictive care decisions and improve
Read More
The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank
Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding Maven Clinic Secures $90M to Advance End-to-End Family Care Platform Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere. Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device
What You Should Know: - Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, have announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various chronic conditions to its AnuraTM platform. - As a first for video-based contactless health monitoring, the new capabilities add to the existing health and wellness measurements* Anura™ can assess from a
Read More
Sprinter Health Partners with Firefly Health to Close Care Gap
What You Should Know: - Sprinter Health, an on-demand mobile health and diagnostics company bringing personalized and affordable healthcare services to the home, today announced a partnership with Firefly Health, a health plan and virtual-first care innovator with a mission of delivering half-priced health care that’s twice as good, clinically and emotionally. - The partnership aims to improve access to care while saving downstream costs by integrating Sprinter Health’s in-home clinical
Read More
Apple Adds Medication Tracking to iPhone. How Will It Impact The Specialty Patient Journey?
Imagine visiting your doctor’s office. Instead of swiping a copay card and filling out a paper form by hand, the receptionist says, “We take Apple Health.” You wave your iPhone over a digital kiosk, instantly uploading your current medical record and insurance information. Your copay is then deducted from a health savings account. Voila! The doctor will see you now. This scenario is no longer relegated to the distant future.
Read More
Ascensia Launches Diabetes Management and Analytics Platform in the U.S
What You Should Know: - Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its online diabetes management and analytics platform GlucoContro.online in the United States. - Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by
Read More
Report: Virtual Care Still in ‘Wild West’ Days Sparking Confusion, High Optimism, Investment
What You Should Know: - A new "State of Virtual Care" report by Omada Health and Digital Medicine Society, in collaboration with Rock Health, reveals that buyers today are inundated with vendors labeling themselves “virtual care providers,” regardless of the care model they’re selling. This phenomenon is blurring their perception of V1C’s potential impact, and what that means for improvements in healthcare delivery and outcomes. - V1C solutions like Omada Health are changing the market,
Read More
